Overview

Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks

Status:
Completed

Trial end date:
2017-01-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to evaluate the effectiveness of ketamine (infusion of 0.5mg/kg) and venlafaxine compared to the use of venlafaxine alone in the treatment of major depression (MADRS score ≥ 20 ) to six weeks of treatment.

Phase:

Phase 3

Details

Lead Sponsor:

University Hospital, Grenoble

Treatments:

Ketamine
Venlafaxine Hydrochloride